Human CD25 ELISA Set
| Code | Size | Price |
|---|
| 851.650.001 | 1 x 96 Discovery | £119.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Human
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)
Further Information
Antigen Synonyms:
IL-2R
Assay Range:
68.75-2220 pg/ml
Cross reaction:
No cross reactivity with other human soluble receptors
Description:
Diaclone ELISA Sets include capture and biotinylated detection antibody one standard per plate Streptavidin-HRP TMB and detailed procedure including buffer composition.
Detection Target:
CD25 / IL-2R
Incubation:
From sample to end 3h45
Reactivity:
Human
Research Area:
Cytokine / Chemokine Receptors
Sample Size:
100 µl
Sample Types:
Serum Plasma Cell culture supernatant
Sensitivity:
8 pg/ml
Specificity:
Recognizes both natural and recombinant human soluble IL-2R
References
- Lebel-Binay S. et al. J Immunol.1995; 155(1): 101-10.. CD82 member of the tetra-span-transmembrane protein family is a costimulatory protein for T cell activation.. https://www.ncbi.nlm.nih.gov/pubmed/7602090
- Popov A. et al.J. Immunol.2008; 181(7): 4976-4988.. Infection of Myeloid Dendritic Cells with Listeria monocytogenes Leads to the Suppression of T Cell Function by Multiple Inhibitory Mechanisms. https://www.ncbi.nlm.nih.gov/pubmed/18802101
- von Bergwelt-Baildon M. S. et al. Blood2006; 108(1): 228-37.. CD25 and indoleamine 23-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. https://www.ncbi.nlm.nih.gov/pubmed/16522817
Related Products
| Product Name | Product Code | Supplier | Accessory pack for ELISA set | 858.000.005 | Diaclone | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|